Abstract
The HIV envelope glycoprotein (Env) trimer undergoes receptor-induced conformational changes that drive fusion of the viral and cellular membranes. Env conformational changes have been observed using low-resolution electron microscopy, but only large-scale rearrangements have been visible. Here, we use hydrogen-deuterium exchange and oxidative labeling to gain a more precise understanding of the unliganded and CD4-bound forms of soluble Env trimers (SOSIP.664), including their glycan composition. CD4 activation induces the reorganization of bridging sheet elements, V1/V2 and V3, much of the gp120 inner domain, and the gp41 fusion subunit. Two CD4 binding site-targeted inhibitors have substantially different effects: NBD-556 partially mimics CD4-induced destabilization of the V1/V2 and V3 crown, whereas BMS-806 only affects regions around the gp120/gp41 interface. The structural information presented here increases our knowledge of CD4- and small molecule-induced conformational changes in Env and the allosteric pathways that lead to membrane fusion.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, Non-P.H.S.
MeSH terms
-
CD4 Antigens / chemistry*
-
CD4 Antigens / metabolism
-
Deuterium Exchange Measurement
-
Glycosylation
-
HEK293 Cells
-
HIV Envelope Protein gp120 / chemistry
-
HIV Envelope Protein gp120 / metabolism
-
HIV Envelope Protein gp41 / chemistry
-
HIV Envelope Protein gp41 / metabolism
-
HIV-1 / drug effects
-
HIV-1 / metabolism
-
HIV-1 / physiology
-
Humans
-
Mass Spectrometry / methods
-
Models, Molecular
-
Oxalates / chemistry
-
Oxalates / metabolism
-
Oxalates / pharmacology
-
Piperazines / chemistry
-
Piperazines / metabolism
-
Piperazines / pharmacology
-
Piperidines / chemistry
-
Piperidines / metabolism
-
Piperidines / pharmacology
-
Protein Binding / drug effects
-
Protein Multimerization*
-
Protein Structure, Quaternary*
-
Solubility
-
env Gene Products, Human Immunodeficiency Virus / chemistry*
-
env Gene Products, Human Immunodeficiency Virus / metabolism
Substances
-
BMS 806
-
CD4 Antigens
-
HIV Envelope Protein gp120
-
HIV Envelope Protein gp41
-
N-(4-chlorophenyl)-N'-(2,2,6,6-tetramethylpiperidin-4-yl)oxalamide
-
Oxalates
-
Piperazines
-
Piperidines
-
env Gene Products, Human Immunodeficiency Virus